Cardioprotection Through Mitochondrial Modulation: A Systematic Review of Pharmacological Interventions in Animal Models of I/R Injury.

In 30 seconds

This systematic review assessed pharmacological interventions in animal models of myocardial ischaemia-reperfusion (I/R), focusing on cardiac outcomes, cell injury and mitochondrial bioenergetics. Eighteen papers, selected from 1571 studies, examined 15 drugs in in vivo or ex vivo models. The review found that interventions targeting electron transport chain complexes or proteins in cardioprotective pathways preserved mitochondrial respiratory capacity. This was accompanied by improved post-ischaemic cardiac function and reductions in cellular injury markers and myocardial infarction. The authors also noted unclear risk of bias in most included papers because study parameters were inadequately reported.

Key findings

• Eighteen papers from 1571 screened studies were included, covering 15 drugs tested in animal I/R models.
• Pharmacological interventions preserved mitochondrial respiratory capacity through direct or indirect targeting of mitochondrial pathways.
• Preserved mitochondrial function was associated with improved post-ischaemic cardiac function and reduced cellular injury markers and myocardial infarction.
• Most papers had unclear risk of bias because of inadequate reporting of study parameters.

Why it matters

Mitochondrial dysfunction is implicated in myocardial injury during reperfusion, and this review links pharmacological preservation of mitochondrial respiratory capacity with better cardiac outcomes in animal models. However, the unsuccessful translation of prior strategies to positive clinical trial outcomes underscores the need for cautious interpretation and better-characterised preclinical evidence before these findings can inform clinical treatment.

What to keep in mind

The evidence comes from animal models, and most included papers had unclear risk of bias because study parameters were inadequately reported.